Key points are not available for this paper at this time.
A-FABP is a key mediator of cerebral ischaemia injury promoting MMP-9-mediated BBB disruption. Inhibition of A-FABP is a potential strategy to improve IS outcome.
Liao et al. (Wed,) studied this question.